N4 Pharma (GB:N4P) has released an update.
N4 Pharma PLC, a specialist pharmaceutical company, has announced the posting of its Annual Report and Accounts for the year ended 31 December 2023 along with the Notice of its upcoming Annual General Meeting (AGM) scheduled for 23 May 2024. The documents are accessible on the company’s website. N4 Pharma is known for developing Nuvec®, an innovative silica nanoparticle delivery system for cancer treatments and vaccines, and aims to generate revenue through partnerships, upfront and milestone payments, and future royalties.
For further insights into GB:N4P stock, check out TipRanks’ Stock Analysis page.
